Home ยป lipids
Tag:

lipids

Health

Black Cumin Seed: Reduces Cholesterol & May Prevent Obesity

by Dr. Michael Lee โ€“ Health Editor
written by Dr. Michael Lee โ€“ Health Editor

Black Cumin Seeds Shownโ€‹ to Considerablyโ€‹ Lower Cholesterol in New study

Tokyo,Japan – A common kitchen spice,black โ€Œcumin ( Nigella sativa),is demonstrating promising results in the fight againstโ€ high cholesterol โคadn obesity,according to a recently published clinicalโ€ trial. Researchers have found that daily consumption of โคblack cumin seed powder can lead to โ€‹significant reductions in โฃtotal cholesterol,โ€Œ LDL-cholesterol, and triglycerides, while simultaneously increasing levels of beneficial HDL-cholesterol.

The randomized controlled trial, conducted by RM Ibrahim et al. and publishedโค in theโฃ Journal of Translational Medicine in 2014, focusedโ€‹ onโข postmenopausal women withโ€Œ lipidโ€Œ disorders. Participantsโข who consumed black cumin seed powder daily for two months experienced marked improvements in their lipid โ€‹profiles compared to a placebo group. This suggests โขblack cumin could be โคa โ€‹valuable “functional food” forโ€Œ preventing lifestyle diseases.

While spicesโ€ like turmeric, ginger, and fenugreek are also being investigated forโฃ their โขmetabolic benefits, black cumin currently boasts the strongest evidence base regarding cholesterol and blood lipid โขmanagement. Researchers, โ€including Kojima-yuasa,โ€‹ are planning larger, longer-term clinical trials โฃto further investigate theโ€‹ spice’s effects โคon insulin resistance in diabetes and inflammatory markers.

“We hope to conduct โ€longer-term, larger-scale clinical trials toโค study the โคeffects of black cuminโ€ onโข metabolism,” โคsays Kojima-Yuasa. “We are โฃparticularlyโฃ interested โฃin studying itsโข effects on insulin resistance in โ€the diabetesโข and on inflammatory markers.”

Despite these encouraging findings, researchers emphasize that black cumin shoudl be โฃconsidered a dietary supplement and not a โฃreplacement for โ€Œa balanced โขdiet and โฃregularโ€Œ medical monitoring. the study authors beleive theโฃ seeds could โคcontribute to preventing obesity and related health โ€issues.

0 comments
0 FacebookTwitterPinterestEmail
Technology

Scientists uncover hidden superfamily of lipid trapping proteins in bacteria

by Rachel Kim โ€“ Technology Editor
written by Rachel Kim โ€“ Technology Editor

Bacterial Protein Discovery Upends Scientific Understanding

A newly identified bacterial protein, PopA, is prompting scientists to rethink how these organisms interact with their environments, potentially paving the way for novel antibacterial strategies.

Unique Protein Structure and Function

Research published in Nature Communications highlights PopA, found in the predatory bacterium Bdellovibrio bacteriovorus, which possesses a distinctive fivefold structure. Advanced imaging revealed its bowl-like shape allows it to trap bacterial membrane components.

When introduced into E. coli, PopA damages their membranes, suggesting a role in Bdellovibrio‘s predatory behavior. Its ability to trap lipids hints at previously unknown bacterial interaction methods.

Widespread Protein Superfamily

Structural and AI analyses showed that PopA homologues across various bacterial species form tetramers, hexamers, and nonamers, all sharing lipid-trapping features. This indicates a widespread, unrecognized protein superfamily.

โ€œOur discovery is significant because it challenges what scientists thought they knew about bacterial proteins. The unique structure and function of PopA suggest that bacteria have more complex ways of interacting with their environments than previously understood.

โ€”Professor Andrew Lovering, Lead Author, University of Birmingham

Another new family of proteins forming ring-like structures was identified, suggesting that the mechanism to combine into rings might be more common than previously thought. The study was supported by the Wellcome Trust, BBSRC, ERC, MRC, and EPSRC.

Implications for Medicine and Biotechnology

According to a 2023 study by the World Health Organization, antibiotic resistance is one of the top 10 global public health threats facing humanity (WHO). This discovery highlights new possibilities for understanding how bacteria function and interact, potentially leading to new ways to target harmful bacteria. This could have important implications for medicine and biotechnology.

Unusual Lipid-Trapping Cavity

Using X-ray crystallography, cryo-electron microscopy, and molecular dynamics, the research team, led by scientists at the University of Birmingham, demonstrated that PopA, previously known as Bd0427, forms a central lipid-trapping cavity. This is unusual given the textbook model of membrane protein formation is centered on excluding lipids.

Outer membrane proteins (OMPs) perform a wide range of functions including signalling, host cell adhesion, catalysis of crucial reactions, and transport of solutes/nutrients. Understanding the natural variability of OMPs may have benefits ranging from antibacterial development to synthetic biology.

0 comments
0 FacebookTwitterPinterestEmail
Health

Study identifies potential way to slow or block progression of age-related macular degeneration

by Dr. Michael Lee โ€“ Health Editor
written by Dr. Michael Lee โ€“ Health Editor

New Hope for Preventing Leading Cause of Blindness

Researchers have discovered a possible method to impede the advancement of age-related macular degeneration (AMD), a prevalent cause of vision loss in people over 50. This research may revolutionize treatments for this debilitating condition, potentially safeguarding eyesight for millions.

Potential Breakthrough in Treating AMD

A recent study conducted by the Washington University School of Medicine in St. Louis has pinpointed a potential method for slowing or even halting the progression of AMD. Scientists, along with their international partners, found that issues with cholesterol metabolism are linked to this form of visual impairment. This offers a fresh explanation for the connection between macular degeneration and cardiovascular disease, both of which are more prevalent with age.

The research, which involved human plasma samples and mouse models of macular degeneration, suggests that boosting the blood’s amount of apolipoprotein M (ApoM) resolves cholesterol processing issues. These issues contribute to cellular damage in the eyes and other organs. This could lead to novel treatments for AMD and possibly some forms of heart failure triggered by similar cholesterol processing problems.

โ€œOur study points to a possible way to address a major unmet clinical need. Current therapies that reduce the chance of further vision loss are limited to only the most advanced stages of macular degeneration and do not reverse the disease. Our findings suggest that developing treatments that increase ApoM levels could treat or even prevent the disease and therefore preserve people’s vision as they age.”

โ€”Rajendra S. Apte, MD, PhD, Senior Author

The study, published in the journal Nature Communications on June 24, further revealed that in people with AMD, doctors can detect cholesterol-rich deposits beneath the retina. In early stages, vision might remain intact, though these deposits exacerbate inflammation. This ultimately leads to a gradual loss of central vision.

According to the CDC, AMD affects around 1.8 million Americans over the age of 40, with numbers expected to rise as the population ages (CDC 2023).

Understanding the Connection

In recent years, evidence has linked ApoM to protective roles in maintaining healthy cholesterol metabolism. Researchers, including Ali Javaheri, MD, PhD, were curious whether declining ApoM levels, common with age, contribute to the dysfunctional cholesterol metabolism implicated in aging-related diseases, like macular degeneration and heart disease.

The study showed that patients with macular degeneration have reduced ApoM levels compared to healthy individuals. Previous work by Dr. Javaheri indicated that patients with heart failure also exhibit lower ApoM levels in the blood.

This research determined that ApoM is vital in “good cholesterol” pathways. These pathways eliminate excess cholesterol from the body via the liver. The findings propose that with low ApoM, cells in the retina and heart have difficulties metabolizing cholesterol deposits. This results in inflammation and cellular damage.

Researchers increased ApoM levels in mouse models of macular degeneration to reverse these harmful effects. This led to improved retinal health, improved function of light-sensing cells, and reduced cholesterol deposits. The researchers also discovered that ApoM needs to bind to sphingosine-1-phosphate (S1P) for its beneficial effects.

Future Implications

Drs. Apte and Javaheri are collaborating with Mobius Scientific, a WashU startup, to translate this understanding of ApoM’s role into novel treatments for AMD. The implications of these findings could also extend to interventions for heart failure patients.

Dr. Javaheri stated, “One of the exciting things about this collaboration is realizing the links between retinal pigment epithelial cells and heart muscle cell, which are both vulnerable to low ApoM. It is possible that the interaction between ApoM and S1P is regulating cholesterol metabolism in both cell types. We look forward to exploring strategies to increase ApoM in ways that could help the eye and the heart maintain healthy cholesterol metabolism over time and stave off two major diseases of aging.“

0 comments
0 FacebookTwitterPinterestEmail
Health

Statins could reduce breast cancer mortality by a fifth

by Dr. Michael Lee โ€“ Health Editor
written by Dr. Michael Lee โ€“ Health Editor

Statins May Significantly Improve Breast Cancer Outcomes

A new analysis involving nearly 700,000 breast cancer cases reveals statins could greatly improve patient outcomes. This challenges previous beliefs about their limited function in cancer care, especially concerning mortality and recurrence.

Statin Impact on Breast Cancer

The research, published in the British Journal of Cancer, investigated the role of statins regarding breast cancer mortality and recurrence. Breast cancer, the most prevalent cancer type, is a leading cause of cancer-related deaths in women. Older women, who are at increased risk, are often prescribed medications like statins to manage cardiovascular risks.

Prior research suggests that statins may be associated with decreased breast cancer recurrence and mortality. However, observed connections between recurrence, mortality, and risk factors could depend on several factors, such as immortal time bias (ITB), the status of estrogen receptors, and cancer stage. These could have altered the size and direction of observations in past meta-analyses without adjustment.

Study Details

The current study included 34 studies, encompassing 689,990 women with breast cancer. Of these, 21 and 20 focused on breast cancer death and recurrence outcomes, respectively. Researchers adjusted most studies for age-related mortality differences and cancer stage. The researchers also considered the timing of statin introduction and the type of statin used.

Besides inhibiting cholesterol synthesis, statins affect the cell cycle, suppressing proliferation and triggering apoptosis. They also impact immune responses. Moreover, the enzyme they inhibit is overexpressed in breast cancers.

Key Findings

The results show that statin usage correlated with a reduced risk of breast cancer death by about 20%. Similar effects were found for recurrence. Lipophilic statins demonstrated a more protective impact than hydrophilic statins against death, although not recurrence, in line with studies showing statins’ anti-proliferative effects on breast cancer cells.

Differences in subgroup outcomes were not statistically significant. This contradicts prior research suggesting, for example, that statins might be more effective in advanced breast cancer. Notably, the current study included few studies involving advanced-stage patients. Further research is necessary to validate this finding.

There was a suggestion of a more protective association in studies with ITB for breast cancer recurrence, but overall, ITB did not appear to significantly bias the main pooled estimates. Similarly, the association for recurrence appeared stronger in estrogen receptor-positive (ER+) patients, consistent with prior findings. Researchers used analysis to assess publication bias, and the protective association remained significant after accounting for potential bias. Statin use appeared to protect against breast cancer recurrence by about 24%.

According to the American Cancer Society, breast cancer accounts for approximately 30% of all new cancer cases in women in the United States (Source). These findings underscore the importance of continued research in this area.

Conclusions

โ€œStatin use, particularly lipophilic statin use, was associated with favorable outcomes for BCD and BCR.โ€ The current study confirms prior analyses on the protective effects of statins on breast cancer mortality and recurrence rates.

This is the first meta-analysis to comprehensively assess effect modifiers, such as ITB and the timing of post-diagnostic statin use. The wide variation in methodologies and outcomes makes it difficult to understand whether the protective effects are due to statins or other factors, such as cardiovascular disease. More research is needed to determine which patient subgroups might benefit from statins as cancer treatment adjuvants.

0 comments
0 FacebookTwitterPinterestEmail
Health

Redefining health science in the age of exposomics

by Dr. Michael Lee โ€“ Health Editor
written by Dr. Michael Lee โ€“ Health Editor

Exposomics: A New Lens on Health’s Environmental Factors

Understanding the Exposome

Exposomics, a rapidly emerging field, investigates how environmental factors influence our health in conjunction with our genetics. It aims to understand the complex interplay between our surroundings and our bodies. This involves studying everything from the air we breathe to the food we consume, and their effects on our overall well-being.

The core idea is that our health is shaped by both our genetic makeup and the world around us. The focus is on understanding how these external factors interact with each other and with our biology. The ultimate goal is to provide a more comprehensive picture of human health and disease.

The recent Banbury Center meeting at Cold Spring Harbor Laboratory brought together experts to develop a framework for translating exposomics into practical biomedical applications. This collaboration of experts from many fields aims to harness the power of exposomics to revolutionize medicine.

The Banbury Exposomics Consortium

The interdisciplinary Banbury Exposomics Consortium published a recent article in Science. It highlighted the critical connection between our genes and the environments we inhabit. The consortium, guided by Rebecca Leshan, the Executive Director of the Banbury Center, includes scientists from diverse fields.

โ€œLife exists at the interface of genetically encoded processes and environmentally driven realities. So too should the biomedical enterprise that studies it.”

โ€”Banbury Exposomics Consortium

The consortium’s work emphasizes the integration of “hard” sciences, like biology and chemistry, with “soft” sciences, such as psychology and economics. This holistic approach sets exposomics apart from related fields, such as environmental health.

Real-World Application

Consider the impact of a chemical spill. While environmental health studies might examine the direct health effects, exposomics delves deeper. It considers the long-term effects, such as job losses or mental health issues. According to the CDC, approximately 1 in 5 US adults experiences mental illness each year (CDC, 2024).

Future Directions

The Science article outlines ambitious goals, including creating a “human exposome” to serve as a reference tool, similar to the Human Genome Project. Moreover, wearable devices that measure a person’s individual exposome could become a reality. This progress could lead to significant health benefits.

If even a fraction of these possibilities are realized, the Banbury Center meeting will be seen as a watershed moment. This will be true not just for exposomics, but for the broader fields of biology and medicine as well.

0 comments
0 FacebookTwitterPinterestEmail
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com